EZZ Life Science

GLENN CROSS

CHAIRMAN

EZZ LIFE SCIENCE HOLDINGS

(ASX:EZZ)

◾ Company Name: EZZ Life Science Holdings ◾ Company ASX code: EZZ ◾ Key areas: Health supplements, health foods, personal care products ◾ Key Personnel: Glenn Cross, Chairman | Mark Qin, CEO and Director | Anthony Guarna – CFO ◾ Locations: Australia, New Zealand, Asia ◾ Market Cap as of 15/09/22: $13.25M ◾ 52 Week share price as of 15 September: $0.270 - $0.595 ◾ Company Website: ezzdna.com

COMPANY PROFILE

EZZ is a genomic life science company with a mission to improve life quality and health in an increasingly global ageing population. The company is focusing its genomic research and product development to isolate and unpack four key areas including:

Genetic longevity, human papillomavirus, helicobacter pylori (a bacteria that grows in the digestive tract which causes stomach ulcers and increases risk of stomach cancers) and weight management.

EZZ has entered local and international university partnerships to drive the momentum of research into human papillomavirus and genetic longevity.

Along with health supplements, health food and probiotics, EZZ, which listed on the ASX in March 2021, has expanded into personal care products leading with a hair care collection.

Ingredients used in the collection contain well-researched components proven to be beneficial to targeting hair problems, including caffeine, amino acids, peptides, and eucalyptus stem cell extract.

EZZ also holds the distribution rights for EAORON skin care products in Australia and New Zealand. Both EZZ and EAORON products are stocked in leading retailers and pharmacies Australia-wide including Chemist Warehouse and Priceline.

Growth has also come from China, where EZZ has established a successful business on e-commerce platforms Tmall Global and TikTok, known as Douyin, and short video platform Kuaishou.

During China’s mid-year e-commerce festival, known as “618” in June, EZZ’s Bone Growth Capsule was ranked the number one product in its category of children’s nutritional supplements on Tmall Global for sales, reviews and repurchase.

EZZ products are also stocked in supermarkets and beauty stores in China, including Sasa in Hong Kong.

EZZ is looking to explore and launch into other potential markets to replicate its China success, including Singapore, Malaysia, Vietnam and the US.

On the financial side, EZZ is one of the rare biotechnology and life sciences companies on the Aussie bourse turning a profit, closing FY22 with a robust cash balance of more than $10M.

The company has earmarked establishing a Good Manufacturing Practice (GMP) certified manufacturing facility in Australia or New Zealand to improve production capabilities and efficiencies.

EZZ is also evaluating potential M&A opportunities to grow and scale the business.

The company has committed to using Australian and certified organic ingredients. As a life sciences company focused on improving people’s health, EZZ believes part of that mission is to also look after the environment which can have a detrimental effect on people’s overall wellbeing.

The company is working to ensure it not only uses natural and organic ingredients as much as possible, but also recyclable and environmentally friendly packaging.

At the helm, EZZ has a strong leadership team, including former CEO and COO of AusBiotech, Glenn Cross, as its chairman and non-executive director.

Cross has more than 40 years’ experience in the life science sector domestically and internationally, including ~20 years’ in senior executive roles.

With its collaborations with world-class research institutions and commitment to strategic integration, Cross believes EZZ is well placed to further expand its business and pursue growth opportunities in the genomics area.

CEO and director, Mark Qin, is an award-winning research analyst and business entrepreneur and author.

KEY INVESTMENT HIGHLIGHTS

◾ EZZ has established a successful and profitable genomic life science company targeting high-quality consumer health products for key healthcare markets benefitting from the world’s ageing populations. ◾ Experienced management team with proven track records to drive growth initiatives such as; new product development, expanded distribution channels, new target markets, and M&A opportunities. ◾ Robust balance sheet, supported by positive operating cash flow, allows EZZ to implement and accelerate strategic growth plans.